BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 288936)

  • 1. Quantitative comparison of BCG strains and preparations in immunotherapy of a rat sarcoma.
    Willmott N; Pimm MV; Baldwin RW
    J Natl Cancer Inst; 1979 Sep; 63(3):787-95. PubMed ID: 288936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCG therapy of pleural and peritoneal growth of transplanted rat tumours.
    Pimm MV; Baldwin RW
    Int J Cancer; 1975 Feb; 15(2):260-9. PubMed ID: 165155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacillus Calmette-Guérin contact immunotherapy of local and metastatic deposits of rat tumors.
    Baldwin RW; Hopper DG; Pimm MV
    Ann N Y Acad Sci; 1976; 277(00):124-34. PubMed ID: 1069545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCG treatment of transplanted rat tumours of spontaneous origin.
    Pimm MV; Cook AJ; Hopper DG; Dickinson AM; Baldwin RW
    Int J Cancer; 1978 Oct; 22(4):426-32. PubMed ID: 700898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative studies of different strains of BCG vaccine in mice: T-cell dependent immune responses.
    Lagrange PH
    Dev Biol Stand; 1977 Apr 13-15; 38():223-9. PubMed ID: 415920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of BCG administered by scarification for immunotherapy of metastatic hepatocarcinoma in the guinea pig.
    Hanna MG; Peters LC; Gutterman JU; Hersh EM
    J Natl Cancer Inst; 1976 May; 56(5):1013-7. PubMed ID: 186611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy of postoperative metastases of 13762A rat mammary adenocarcinoma: comparative effectiveness of BCG substrains and methods of preparation.
    Kreider JW; Bartlett GL; Purnell DM
    Cancer; 1980 Aug; 46(3):500-7. PubMed ID: 7397623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCG immunotherapy of pulmonary growths from intravenously transferred rat tumour cells.
    Baldwin RW; Pimm MV
    Br J Cancer; 1973 Jan; 27(1):48-54. PubMed ID: 4686177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacillus Calmette-Guérin strain differences have an impact on clinical outcome in bladder cancer immunotherapy.
    Rentsch CA; Birkhäuser FD; Biot C; Gsponer JR; Bisiaux A; Wetterauer C; Lagranderie M; Marchal G; Orgeur M; Bouchier C; Bachmann A; Ingersoll MA; Brosch R; Albert ML; Thalmann GN
    Eur Urol; 2014 Oct; 66(4):677-88. PubMed ID: 24674149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCG treatment of malignant pleural effusions in the rat.
    Pimm MV; Hopper DG; Baldwin RW
    Br J Cancer; 1976 Oct; 34(4):368-73. PubMed ID: 184810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methanol extraction residue of BCG in the treatment of transplanted rat tumours.
    Hopper DG; Pimm MV; Baldwin RW
    Br J Cancer; 1975 Feb; 31(2):176-81. PubMed ID: 169861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicity of intrapleural Bacillus Calmette-Guérin treatment in animals.
    Filardi MJ; Codish SD; Civerchia L; Howard RK; McKneally MF
    Cancer Res; 1979 Sep; 39(9):3673-6. PubMed ID: 383285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization of mice after airborne infection with various strains of BCG.
    Lefford MJ
    Am Rev Respir Dis; 1978 Jan; 117(1):103-9. PubMed ID: 339795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of BCG and C. parvum preparations for adjuvant contact therapy of a rat sarcoma.
    Wilmott N; Pimm MV; Baldwin RW
    Dev Biol Stand; 1977 Apr 13-15; 38():39-43. PubMed ID: 608529
    [No Abstract]   [Full Text] [Related]  

  • 15. BCG immunotherapy: effects of dose and route of administration on survival of mice bearing established tumors.
    Codish SD; Monaco AP
    J Surg Oncol; 1978; 10(5):447-55. PubMed ID: 732331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCG immunotherapy of a rat sarcoma.
    Baldwin RW; Pimm MV
    Br J Cancer; 1973 Oct; 28(4):281-7. PubMed ID: 4759936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proceedings: B.C.G. treatment of pleural and peritoneal tumour growth in rats.
    Pimm MV
    Br J Cancer; 1974 Aug; 30(2):183. PubMed ID: 4419321
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the potentiation of specific tumor immunity in mice by Corynebacterium parvum or BCG.
    Scott MT; Bomford R
    J Natl Cancer Inst; 1976 Sep; 57(3):555-9. PubMed ID: 978769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunotherapeutic effect of orally administered BCG on experimental lung metastasis of subcutaneous fibrosarcoma in guinea pigs].
    Fujisawa S
    Nihon Hifuka Gakkai Zasshi; 1982; 92(8):871-81. PubMed ID: 6983601
    [No Abstract]   [Full Text] [Related]  

  • 20. The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non-muscle-invasive bladder cancer.
    Witjes JA; Dalbagni G; Karnes RJ; Shariat S; Joniau S; Palou J; Serretta V; Larré S; di Stasi S; Colombo R; Babjuk M; Malmström PU; Malats N; Irani J; Baniel J; Cai T; Cha E; Ardelt P; Varkarakis J; Bartoletti R; Spahn M; Pisano F; Gontero P; Sylvester R
    Urol Oncol; 2016 Nov; 34(11):484.e19-484.e25. PubMed ID: 27639776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.